142 related articles for article (PubMed ID: 38419802)
1. Effects of nuclear interaction corrections and trichrome fragment spectra modelling on dose and linear energy transfer distributions in carbon ion radiotherapy.
Bazani A; Brunner J; Russo S; Carlino A; Simon Colomar D; Ikegami Andersson W; Ciocca M; Stock M; Fossati P; Orlandi E; Glimelius L; Molinelli S; Knäusl B
Phys Imaging Radiat Oncol; 2024 Jan; 29():100553. PubMed ID: 38419802
[TBL] [Abstract][Full Text] [Related]
2. Dose averaged linear energy transfer optimization for large sacral chordomas in carbon ion therapy.
Schafasand M; Resch AF; Nachankar A; Góra J; Martino G; Traneus E; Glimelius L; Georg D; Fossati P; Carlino A; Stock M
Med Phys; 2024 May; ():. PubMed ID: 38696546
[TBL] [Abstract][Full Text] [Related]
3. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy.
Hahn C; Eulitz J; Peters N; Wohlfahrt P; Enghardt W; Richter C; Lühr A
Med Phys; 2020 Dec; 47(12):6151-6162. PubMed ID: 33118161
[TBL] [Abstract][Full Text] [Related]
4. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
[TBL] [Abstract][Full Text] [Related]
5. Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges.
Hahn C; Heuchel L; Ödén J; Traneus E; Wulff J; Plaude S; Timmermann B; Bäumer C; Lühr A
Radiat Oncol; 2022 Oct; 17(1):169. PubMed ID: 36273132
[TBL] [Abstract][Full Text] [Related]
6. How LEM-based RBE and dose-averaged LET affected clinical outcomes of sacral chordoma patients treated with carbon ion radiotherapy.
Molinelli S; Magro G; Mairani A; Allajbej A; Mirandola A; Chalaszczyk A; Imparato S; Ciocca M; Fiore MR; Orlandi E
Radiother Oncol; 2021 Oct; 163():209-214. PubMed ID: 34506829
[TBL] [Abstract][Full Text] [Related]
7. Sacral-Nerve-Sparing Planning Strategy in Pelvic Sarcomas/Chordomas Treated with Carbon-Ion Radiotherapy.
Nachankar A; Schafasand M; Hug E; Martino G; Góra J; Carlino A; Stock M; Fossati P
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610962
[TBL] [Abstract][Full Text] [Related]
8. Calculating dose-averaged linear energy transfer in an analytical treatment planning system for carbon-ion radiotherapy.
Wang W; Li P; Shahnazi K; Wu X; Zhao J
J Appl Clin Med Phys; 2023 Feb; 24(2):e13866. PubMed ID: 36527366
[TBL] [Abstract][Full Text] [Related]
9. High-Linear Energy Transfer Irradiation in Clinical Carbon-Ion Beam With the Linear Energy Transfer Painting Technique for Patients With Head and Neck Cancer.
Kohno R; Koto M; Ikawa H; Lee SH; Sato K; Hashimoto M; Inaniwa T; Shirai T
Adv Radiat Oncol; 2024 Jan; 9(1):101317. PubMed ID: 38260238
[TBL] [Abstract][Full Text] [Related]
10. Planning Strategy to Optimize the Dose-Averaged LET Distribution in Large Pelvic Sarcomas/Chordomas Treated with Carbon-Ion Radiotherapy.
Nachankar A; Schafasand M; Carlino A; Hug E; Stock M; Góra J; Fossati P
Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835598
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of dose-averaged linear energy transfer (LET
Rana S; Traneus E; Jackson M; Tran L; Rosenfeld AB
Med Phys; 2022 May; 49(5):3444-3456. PubMed ID: 35194809
[TBL] [Abstract][Full Text] [Related]
12. An analytical dose-averaged LET calculation algorithm considering the off-axis LET enhancement by secondary protons for spot-scanning proton therapy.
Hirayama S; Matsuura T; Ueda H; Fujii Y; Fujii T; Takao S; Miyamoto N; Shimizu S; Fujimoto R; Umegaki K; Shirato H
Med Phys; 2018 Jul; 45(7):3404-3416. PubMed ID: 29788552
[TBL] [Abstract][Full Text] [Related]
13. FRoG: An independent dose and LET
Kopp B; Fuglsang Jensen M; Mein S; Hoffmann L; Nyström H; Falk M; Haberer T; Abdollahi A; Debus J; Mairani A
Med Phys; 2020 Oct; 47(10):5274-5286. PubMed ID: 32737870
[TBL] [Abstract][Full Text] [Related]
14. Validation of linear energy transfer computed in a Monte Carlo dose engine of a commercial treatment planning system.
Wagenaar D; Tran LT; Meijers A; Marmitt GG; Souris K; Bolst D; James B; Biasi G; Povoli M; Kok A; Traneus E; van Goethem MJ; Langendijk JA; Rosenfeld AB; Both S
Phys Med Biol; 2020 Jan; 65(2):025006. PubMed ID: 31801119
[TBL] [Abstract][Full Text] [Related]
15. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.
Henry T; Ödén J
Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384
[TBL] [Abstract][Full Text] [Related]
16. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
Traneus E; Ödén J
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code.
Guan F; Peeler C; Bronk L; Geng C; Taleei R; Randeniya S; Ge S; Mirkovic D; Grosshans D; Mohan R; Titt U
Med Phys; 2015 Nov; 42(11):6234-47. PubMed ID: 26520716
[TBL] [Abstract][Full Text] [Related]
18. Biological Dose Optimization for Particle Arc Therapy Using Helium and Carbon Ions.
Mein S; Tessonnier T; Kopp B; Schömers C; Harrabi S; Abdollahi A; Debus J; Haberer T; Mairani A
Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):334-348. PubMed ID: 35490991
[TBL] [Abstract][Full Text] [Related]
19. A trichrome beam model for biological dose calculation in scanned carbon-ion radiotherapy treatment planning.
Inaniwa T; Kanematsu N
Phys Med Biol; 2015 Jan; 60(1):437-51. PubMed ID: 25658007
[TBL] [Abstract][Full Text] [Related]
20. Technical note: Impact of beamline-specific particle energy spectra on clinical plans in carbon ion beam therapy.
Resch AF; Schafasand M; Lackner N; Niessen T; Beck S; Elia A; Boersma D; Grevillot L; Fossati P; Glimelius L; Stock M; Georg D; Carlino A
Med Phys; 2022 Jun; 49(6):4092-4098. PubMed ID: 35416302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
